Ascribe Extends Integrated Pharmacy and Robotic IT Systems to Royal Bolton Hospital

Ascribe plc (AIM:ASP), the innovative health IT Group, today announced that it has successfully installed its Web Pharmacy solution at the Royal Bolton Hospital, part of the Bolton Hospitals NHS Trust and that the site is completely operational. One unique aspect of this 'Go Live' was that, on the same day that the hospital changed its pharmacy IT system, they also brought online a robotic dispensing system; thereby taking a massive leap forward in improving patient care and safety.

The Ascribe Web enabled pharmacy system is designed by healthcare clinicians to ensure higher patient safety standards. It achieves this by using a patient's medication record which effectively warns pharmacy staff automatically, via use of its integrated decision support service, if there may be a dangerous drug interaction or allergic reaction arising from the dispensed medications.

The Ascribe pharmacy system was selected by Bolton Hospital NHS Trust because it extends such a broad range of complementary pharmacy services outside of the dispensary. The system has been designed to allow ward-based clinical services, such as medicines management (whereby medicines can be ordered wirelessly from the wards) and electronic prescribing and medicine administration (which records exactly what medication was prescribed, when the medication was administered to the patient, and what reaction was noted). In addition to this, the Ascribe pharmacy system also provides the hospital pharmacy staff with a bi-directional interface from their pharmacy system to their Rowa Speedcase Robotic Dispensing unit, allowing pharmacists to both issue requests for prescriptions to their robotic system and receive (stock level) updates from their robot.

Brian Smith, Chief Pharmacist at the Royal Bolton Hospital said "The Bolton Hospitals NHS Trust is delighted that Ascribe was able to deliver such a robust and flexible pharmacy system within a twelve week project cycle. Our staff has welcomed the additional patient safety features that are embedded within the system and we look forward to extending our pharmacy services beyond the pharmacy itself, thereby saving time and providing a higher level of service to our clinicians and patients."

Stephen Critchlow, Executive Chairman of Ascribe plc said "Ascribe is delighted that the Royal Bolton has taken this step to improve patient safety standards. Our technology enables Hospitals to provide their clinicians with comprehensive and relevant information when and where healthcare decisions are made. This technology is in increasing demand and we have recently sold similar systems in the UK (at Addenbrookes Hospital, part of the Cambridge University Hospitals NHS Foundation Trust), and overseas in Australia & New Zealand."

For further information, please visit:
http://www.ascribe.com

About Ascribe
Ascribe plc is a leading healthcare company that develops and markets software solutions supporting patient, clinical and business processes to Primary & Secondary healthcare providers in the UK and overseas.

Ascribe is committed to providing technologies that improve patient safety standards and the company's solutions directly improve patient care and deliver financial savings to customers. The Group sells directly to hospitals and Primary Care Trusts rather than through centrally driven political initiatives.

The Group provides solutions to clinical professionals in all healthcare sectors; customers include Emergency and Minor Injuries Units, Mental Health and Social Care Units, Hospitals requiring patient administration systems (PAS) and medical equipment management, Hospital and Retail Pharmacies, and General Practice surgeries. Offering patient and decision support information to these clinicians in context with their activity is the key to the company's ongoing success.

Ascribe plc was floated on AIM in 2004, and currently employs over 220 personnel through its operating companies in the UK, Kenya, Australia and New Zealand.

For more information, please visit www.ascribe.com.

About Bolton Hospitals NHS Trust
Bolton Hospitals NHS Trust offers patients a wide range of services based at the Royal Bolton Hospital as well as some which take place in community settings. It is the Trust's aim to have the best hospital in the NHS by providing best possible care for our patients, improved health for local people, and joy and pride in work for our staff. Bolton Hospitals NHS Trust was formed in April 1994 and now serves the population of Bolton (around 265,000) plus some neighbouring areas. The Trust employs over 3,100 staff.

Most Popular Now

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Ancient viral DNA in human genome guards against i…

Viral DNA in human genomes, embedded there from ancient infections, serve as antivirals that protect human cells against certain present-day viruses, according to new res...

The origin-of-life molecule, a key to cancer resea…

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cance...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...